Literature DB >> 26169747

[Fibromyalgia syndrome: A disease of the small nerve fibers?].

N Üçeyler1, C Sommer.   

Abstract

Fibromyalgia syndrome (FMS) is characterized by chronic widespread pain and additional associated symptoms, such as fatigue, sleep disturbances and depressive moods. The pathophysiology of pain in FMS is unclear. In recent years, an involvement of the thinly myelinated A-delta and the unmyelinated C-nerve fibers has been reported in FMS patients. Independent research groups published consistent objective and multidimensional findings of damage to these small nerve fibers, such as disturbances of fiber function, electrical properties and morphological changes. All these alterations are not specific for FMS; however, they were described for the first time in subgroups of FMS patients. While the reasons for this small fiber pathology and its contribution to FMS pain are still unclear, a new research field has now been opened that will focus on uncovering the underlying pathophysiology. This review article summarizes these new findings and discusses the significance for the understanding of FMS.

Entities:  

Mesh:

Year:  2015        PMID: 26169747     DOI: 10.1007/s00393-014-1546-1

Source DB:  PubMed          Journal:  Z Rheumatol        ISSN: 0340-1855            Impact factor:   1.372


  28 in total

1.  Dysfunction of small myelinated afferents in diabetic polyneuropathy, as assessed by laser evoked potentials.

Authors:  R Agostino; G Cruccu; A Romaniello; P Innocenti; M Inghilleri; M Manfredi
Journal:  Clin Neurophysiol       Date:  2000-02       Impact factor: 3.708

2.  [Etiology and pathophysiology of fibromyalgia syndrome].

Authors:  C Sommer; W Häuser; M Burgmer; R Engelhardt; K Gerhold; F Petzke; T Schmidt-Wilcke; M Späth; T Tölle; N Uçeyler; H Wang; A Winkelmann; K Thieme
Journal:  Schmerz       Date:  2012-06       Impact factor: 1.107

3.  Hyperexcitable C nociceptors in fibromyalgia.

Authors:  Jordi Serra; Antonio Collado; Romà Solà; Francesca Antonelli; Xavier Torres; Monika Salgueiro; Cristina Quiles; Hugh Bostock
Journal:  Ann Neurol       Date:  2014-02-12       Impact factor: 10.422

4.  Reduced levels of antiinflammatory cytokines in patients with chronic widespread pain.

Authors:  Nurcan Uçeyler; Regine Valenza; Michael Stock; Robert Schedel; Günter Sprotte; Claudia Sommer
Journal:  Arthritis Rheum       Date:  2006-08

5.  Objective evidence that small-fiber polyneuropathy underlies some illnesses currently labeled as fibromyalgia.

Authors:  Anne Louise Oaklander; Zeva Daniela Herzog; Heather M Downs; Max M Klein
Journal:  Pain       Date:  2013-06-05       Impact factor: 6.961

6.  Small fibre pathology in patients with fibromyalgia syndrome.

Authors:  Nurcan Üçeyler; Daniel Zeller; Ann-Kathrin Kahn; Susanne Kewenig; Sarah Kittel-Schneider; Annina Schmid; Jordi Casanova-Molla; Karlheinz Reiners; Claudia Sommer
Journal:  Brain       Date:  2013-03-09       Impact factor: 13.501

7.  [What are the key symptoms of fibromyalgia? Results of a survey of the German Fibromyalgia Association].

Authors:  W Häuser; C Zimmer; E Felde; V Köllner
Journal:  Schmerz       Date:  2008-04       Impact factor: 1.107

8.  Abnormal spontaneous activity in single sensory nerve fibers in humans.

Authors:  J Ochoa; H E Torebjörk; W J Culp; W Schady
Journal:  Muscle Nerve       Date:  1982       Impact factor: 3.217

9.  Prevalence of fibromyalgia: a survey in five European countries.

Authors:  Jaime C Branco; Bernard Bannwarth; Inmaculada Failde; Jordi Abello Carbonell; Francis Blotman; Michael Spaeth; Fernando Saraiva; Francesca Nacci; Eric Thomas; Jean-Paul Caubère; Katell Le Lay; Charles Taieb; Marco Matucci-Cerinic
Journal:  Semin Arthritis Rheum       Date:  2009-02-27       Impact factor: 5.532

Review 10.  Biology and therapy of fibromyalgia. Evidence-based biomarkers for fibromyalgia syndrome.

Authors:  Dina Dadabhoy; Leslie J Crofford; Michael Spaeth; I Jon Russell; Daniel J Clauw
Journal:  Arthritis Res Ther       Date:  2008-08-08       Impact factor: 5.156

View more
  6 in total

Review 1.  Fibromyalgia: Pathogenesis, Mechanisms, Diagnosis and Treatment Options Update.

Authors:  Rosalba Siracusa; Rosanna Di Paola; Salvatore Cuzzocrea; Daniela Impellizzeri
Journal:  Int J Mol Sci       Date:  2021-04-09       Impact factor: 5.923

2.  Increased expression of Trpv1 in peripheral terminals mediates thermal nociception in Fabry disease mouse model.

Authors:  Jarmila Lakomá; Roberto Rimondini; Antonio Ferrer Montiel; Vincenzo Donadio; Rocco Liguori; Marco Caprini
Journal:  Mol Pain       Date:  2016-08-16       Impact factor: 3.395

3.  Response to: Comment on "Cost-Saving Early Diagnosis of Functional Pain in Nonmalignant Pain: A Noninferiority Study of Diagnostic Accuracy".

Authors:  N Egloff; R J Cámara; C Merz; B Wegmann; S Stauber; R von Känel
Journal:  Pain Res Treat       Date:  2016-11-29

4.  Pain Processing and Vegetative Dysfunction in Fibromyalgia: A Study by Sympathetic Skin Response and Laser Evoked Potentials.

Authors:  Marina de Tommaso; Katia Ricci; Giuseppe Libro; Eleonora Vecchio; Marianna Delussi; Anna Montemurno; Giuseppe Lopalco; Florenzo Iannone
Journal:  Pain Res Treat       Date:  2017-09-28

5.  The link between idiopathic intracranial hypertension, fibromyalgia, and chronic fatigue syndrome: exploration of a shared pathophysiology.

Authors:  Mieke Hulens; Ricky Rasschaert; Greet Vansant; Ingeborg Stalmans; Frans Bruyninckx; Wim Dankaerts
Journal:  J Pain Res       Date:  2018-12-10       Impact factor: 3.133

Review 6.  Mycotherapy: Potential of Fungal Bioactives for the Treatment of Mental Health Disorders and Morbidities of Chronic Pain.

Authors:  Elaine Meade; Sarah Hehir; Neil Rowan; Mary Garvey
Journal:  J Fungi (Basel)       Date:  2022-03-11
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.